HHS OIG Proposed Rule on the Safe Harbor for Pharmaceutical Rebates: The Issues and Impact

In this on-demand webinar, we discuss the key takeaways of the proposed rule, including its potential impact, if finalized, on various stakeholders, including PBMs, health plans, drug manufacturers, and pharmacies.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Cancer Gene Expression Targets Validated Using Novel Histopathology Tools

Advanced Cell Diagnostics Inc.

When assessing a potential biological therapeutic candidate, several histopathological technologies are typically employed. This ensures the target expression is validated in both normal and diseased tissues before proceeding with pre-clinical studies. Protein B is a transmembrane glycoprotein that is overexpressed in numerous cancers, including triple-negative breast cancer and is often correlated with the metastatic phenotype. In this GEN webinar, we will discuss the process involved in a typical molecular pathology laboratory.
Watch Now

Empower your drug design & synthesis with vibrational circular dichroism (VCD)

Vibrational Circular Dichroism (VCD) is used to determine the absolute configuration of compounds in solution. As a result, it doesn’t require crystalline substances.
Watch Now

Membrane-Based Water for Injection

ON24

Historically, distillation has been the most common technology used to produce Water for Injection (WFI), due to prior process advantages and historical regulatory requirements. Changes in the European Pharmacopeiano longer require the use of distillation systems to produce WFI. In this webcast, learn about the impact of this regulatory change on water system design and how reverse osmosis and ultrafiltration can be used to produce WFI with significant lifecycle cost advantages.
Watch Now

Overcoming Challenges in Ophthalmic Drug Delivery Including Bioavailability and Sterility

Pharmtech

Delivery of therapeutics to the human eye is one of the most interesting—but challenging—endeavors a formulator can take on. The anatomy and chemical composition of the eye make it highly resistant to pharmaceutical penetration. Successfully circumventing these protective barriers requires intimate knowledge of ocular delivery as well as specialized development and manufacturing expertise.
Watch Now

Spotlight

resources